• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Ocular Drug Delivery Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 127 Pages
  • Report Code: 24LS-21571
  • Formate :   
Download FREE Report Sample Download PDF File

United States Ocular Drug Delivery -MARKET ADVISORY SERVICES

Ocular Drug Delivery market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Ocular Drug Delivery market is segmented into
By Technology
By Form

Segment by Application, the Ocular Drug Delivery market is segmented into
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings

Regional and Country-level Analysis
The Ocular Drug Delivery market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ocular Drug Delivery market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Ocular Drug Delivery Market Share Analysis
Ocular Drug Delivery market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ocular Drug Delivery business, the date to enter into the Ocular Drug Delivery market, Ocular Drug Delivery product introduction, recent developments, etc.
The major vendors covered:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
1 Study Coverage
1.1 Ocular Drug Delivery Product Introduction
1.2 Market Segments
1.3 Key Ocular Drug Delivery Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ocular Drug Delivery Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Ocular Drug Delivery Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Ophthalmic Clinics
1.5.5 Homecare Settings
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ocular Drug Delivery Market Size, Estimates and Forecasts
2.1.1 Global Ocular Drug Delivery Revenue 2015-2026
2.1.2 Global Ocular Drug Delivery Sales 2015-2026
2.2 Global Ocular Drug Delivery, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Ocular Drug Delivery Historical Market Size by Region (2015-2020)
2.3.1 Global Ocular Drug Delivery Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Ocular Drug Delivery Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Ocular Drug Delivery Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Ocular Drug Delivery Sales Forecast by Region (2021-2026)
2.4.2 Global Ocular Drug Delivery Revenue Forecast by Region (2021-2026)

3 Global Ocular Drug Delivery Competitor Landscape by Players
3.1 Global Top Ocular Drug Delivery Sales by Manufacturers
3.1.1 Global Ocular Drug Delivery Sales by Manufacturers (2015-2020)
3.1.2 Global Ocular Drug Delivery Sales Market Share by Manufacturers (2015-2020)
3.2 Global Ocular Drug Delivery Manufacturers by Revenue
3.2.1 Global Ocular Drug Delivery Revenue by Manufacturers (2015-2020)
3.2.2 Global Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ocular Drug Delivery Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Revenue in 2019
3.2.5 Global Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Ocular Drug Delivery Price by Manufacturers
3.4 Global Ocular Drug Delivery Manufacturing Base Distribution, Product Types
3.4.1 Ocular Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ocular Drug Delivery Product Type
3.4.3 Date of International Manufacturers Enter into Ocular Drug Delivery Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Ocular Drug Delivery Market Size by Type (2015-2020)
4.1.1 Global Ocular Drug Delivery Sales by Type (2015-2020)
4.1.2 Global Ocular Drug Delivery Revenue by Type (2015-2020)
4.1.3 Ocular Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ocular Drug Delivery Market Size Forecast by Type (2021-2026)
4.2.1 Global Ocular Drug Delivery Sales Forecast by Type (2021-2026)
4.2.2 Global Ocular Drug Delivery Revenue Forecast by Type (2021-2026)
4.2.3 Ocular Drug Delivery Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ocular Drug Delivery Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Ocular Drug Delivery Market Size by Application (2015-2020)
5.1.1 Global Ocular Drug Delivery Sales by Application (2015-2020)
5.1.2 Global Ocular Drug Delivery Revenue by Application (2015-2020)
5.1.3 Ocular Drug Delivery Price by Application (2015-2020)
5.2 Ocular Drug Delivery Market Size Forecast by Application (2021-2026)
5.2.1 Global Ocular Drug Delivery Sales Forecast by Application (2021-2026)
5.2.2 Global Ocular Drug Delivery Revenue Forecast by Application (2021-2026)
5.2.3 Global Ocular Drug Delivery Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Ocular Drug Delivery Market Size YoY Growth 2015-2026
6.1.1 United States Ocular Drug Delivery Sales YoY Growth 2015-2026
6.1.2 United States Ocular Drug Delivery Revenue YoY Growth 2015-2026
6.1.3 United States Ocular Drug Delivery Market Share in Global Market 2015-2026
6.2 United States Ocular Drug Delivery Market Size by Players (International and Local Players)
6.2.1 United States Top Ocular Drug Delivery Players by Sales (2015-2020)
6.2.2 United States Top Ocular Drug Delivery Players by Revenue (2015-2020)
6.3 United States Ocular Drug Delivery Historic Market Review by Type (2015-2020)
6.3.1 United States Ocular Drug Delivery Sales Market Share by Type (2015-2020)
6.3.2 United States Ocular Drug Delivery Revenue Market Share by Type (2015-2020)
6.3.3 United States Ocular Drug Delivery Price by Type (2015-2020)
6.4 United States Ocular Drug Delivery Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Ocular Drug Delivery Sales Forecast by Type (2021-2026)
6.4.2 United States Ocular Drug Delivery Revenue Forecast by Type (2021-2026)
6.4.3 United States Ocular Drug Delivery Price Forecast by Type (2021-2026)
6.5 United States Ocular Drug Delivery Historic Market Review by Application (2015-2020)
6.5.1 United States Ocular Drug Delivery Sales Market Share by Application (2015-2020)
6.5.2 United States Ocular Drug Delivery Revenue Market Share by Application (2015-2020)
6.5.3 United States Ocular Drug Delivery Price by Application (2015-2020)
6.6 United States Ocular Drug Delivery Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Ocular Drug Delivery Sales Forecast by Application (2021-2026)
6.6.2 United States Ocular Drug Delivery Revenue Forecast by Application (2021-2026)
6.6.3 United States Ocular Drug Delivery Price Forecast by Application (2021-2026)

7 North America
7.1 North America Ocular Drug Delivery Market Size YoY Growth 2015-2026
7.2 North America Ocular Drug Delivery Market Facts & Figures by Country
7.2.1 North America Ocular Drug Delivery Sales by Country (2015-2020)
7.2.2 North America Ocular Drug Delivery Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Ocular Drug Delivery Market Size YoY Growth 2015-2026
8.2 Europe Ocular Drug Delivery Market Facts & Figures by Country
8.2.1 Europe Ocular Drug Delivery Sales by Country
8.2.2 Europe Ocular Drug Delivery Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Ocular Drug Delivery Market Size YoY Growth 2015-2026
9.2 Asia Pacific Ocular Drug Delivery Market Facts & Figures by Country
9.2.1 Asia Pacific Ocular Drug Delivery Sales by Region (2015-2020)
9.2.2 Asia Pacific Ocular Drug Delivery Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Ocular Drug Delivery Market Size YoY Growth 2015-2026
10.2 Latin America Ocular Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Ocular Drug Delivery Sales by Country
10.2.2 Latin America Ocular Drug Delivery Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Ocular Drug Delivery Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Ocular Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Ocular Drug Delivery Sales by Country
11.2.2 Middle East and Africa Ocular Drug Delivery Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 OCULAR THERAPEUTIX, INC
12.1.1 OCULAR THERAPEUTIX, INC Corporation Information
12.1.2 OCULAR THERAPEUTIX, INC Description and Business Overview
12.1.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
12.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
12.1.5 OCULAR THERAPEUTIX, INC Recent Development
12.2 Alimera Sciences
12.2.1 Alimera Sciences Corporation Information
12.2.2 Alimera Sciences Description and Business Overview
12.2.3 Alimera Sciences Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alimera Sciences Ocular Drug Delivery Products Offered
12.2.5 Alimera Sciences Recent Development
12.3 Allergan, Plc
12.3.1 Allergan, Plc Corporation Information
12.3.2 Allergan, Plc Description and Business Overview
12.3.3 Allergan, Plc Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Allergan, Plc Ocular Drug Delivery Products Offered
12.3.5 Allergan, Plc Recent Development
12.4 EyeGate Pharma
12.4.1 EyeGate Pharma Corporation Information
12.4.2 EyeGate Pharma Description and Business Overview
12.4.3 EyeGate Pharma Sales, Revenue and Gross Margin (2015-2020)
12.4.4 EyeGate Pharma Ocular Drug Delivery Products Offered
12.4.5 EyeGate Pharma Recent Development
12.5 Valeant Pharmaceuticals International, Inc
12.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
12.5.2 Valeant Pharmaceuticals International, Inc Description and Business Overview
12.5.3 Valeant Pharmaceuticals International, Inc Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Products Offered
12.5.5 Valeant Pharmaceuticals International, Inc Recent Development
12.6 Envisia Therapeutics
12.6.1 Envisia Therapeutics Corporation Information
12.6.2 Envisia Therapeutics Description and Business Overview
12.6.3 Envisia Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Envisia Therapeutics Ocular Drug Delivery Products Offered
12.6.5 Envisia Therapeutics Recent Development
12.7 Clearside Biomedical
12.7.1 Clearside Biomedical Corporation Information
12.7.2 Clearside Biomedical Description and Business Overview
12.7.3 Clearside Biomedical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Clearside Biomedical Ocular Drug Delivery Products Offered
12.7.5 Clearside Biomedical Recent Development
12.8 Graybug Vision Inc
12.8.1 Graybug Vision Inc Corporation Information
12.8.2 Graybug Vision Inc Description and Business Overview
12.8.3 Graybug Vision Inc Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Graybug Vision Inc Ocular Drug Delivery Products Offered
12.8.5 Graybug Vision Inc Recent Development
12.9 Taiwan Liposome Company
12.9.1 Taiwan Liposome Company Corporation Information
12.9.2 Taiwan Liposome Company Description and Business Overview
12.9.3 Taiwan Liposome Company Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Taiwan Liposome Company Ocular Drug Delivery Products Offered
12.9.5 Taiwan Liposome Company Recent Development
12.10 Santen Pharmaceutical
12.10.1 Santen Pharmaceutical Corporation Information
12.10.2 Santen Pharmaceutical Description and Business Overview
12.10.3 Santen Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Santen Pharmaceutical Ocular Drug Delivery Products Offered
12.10.5 Santen Pharmaceutical Recent Development
12.11 OCULAR THERAPEUTIX, INC
12.11.1 OCULAR THERAPEUTIX, INC Corporation Information
12.11.2 OCULAR THERAPEUTIX, INC Description and Business Overview
12.11.3 OCULAR THERAPEUTIX, INC Sales, Revenue and Gross Margin (2015-2020)
12.11.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Products Offered
12.11.5 OCULAR THERAPEUTIX, INC Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ocular Drug Delivery Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ocular Drug Delivery Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Ocular Drug Delivery Market Segments

Table 2. Ranking of Global Top Ocular Drug Delivery Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Ocular Drug Delivery Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)

Table 4. Major Manufacturers of Type I

Table 5. Major Manufacturers of Type II

Table 6. Global Ocular Drug Delivery Market Size Growth Rate by Application 2020-2026 (K Doses)

Table 7. Global Ocular Drug Delivery Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026

Table 8. Global Ocular Drug Delivery Sales by Regions 2015-2020 (K Doses)

Table 9. Global Ocular Drug Delivery Sales Market Share by Regions (2015-2020)

Table 10. Global Ocular Drug Delivery Revenue by Regions 2015-2020 (US$ Million)

Table 11. Global Ocular Drug Delivery Sales Forecast by Region (2021-2026) (K Doses)

Table 12. Global Ocular Drug Delivery Sales by Manufacturers (2015-2020) (K Doses)

Table 13. Global Ocular Drug Delivery Sales Share by Manufacturers (2015-2020)

Table 14. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 15. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Drug Delivery as of 2019)

Table 16. Ocular Drug Delivery Revenue by Manufacturers (2015-2020) (US$ Million)

Table 17. Ocular Drug Delivery Revenue Share by Manufacturers (2015-2020)

Table 18. Key Manufacturers Ocular Drug Delivery Price (2015-2020) (USD/Dose)

Table 19. Ocular Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters

Table 20. Manufacturers Ocular Drug Delivery Product Type

Table 21. Date of International Manufacturers Enter into Ocular Drug Delivery Market

Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 23. Global Ocular Drug Delivery Sales by Type (2015-2020) (K Doses)

Table 24. Global Ocular Drug Delivery Sales Share by Type (2015-2020)

Table 25. Global Ocular Drug Delivery Revenue by Type (2015-2020) (US$ Million)

Table 26. Global Ocular Drug Delivery Revenue Share by Type (2015-2020)

Table 27. Ocular Drug Delivery Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)

Table 28. Global Ocular Drug Delivery Sales Share by Type (2021-2026)

Table 29. Global Ocular Drug Delivery Sales by Application (2015-2020) (K Doses)

Table 30. Global Ocular Drug Delivery Sales Share by Application (2015-2020)

Table 31. Global Ocular Drug Delivery Sales Share by Application (2021-2026)

Table 32. Global Ocular Drug Delivery Sales Market Share Forecast by Application (2021-2026)

Table 33. Global Ocular Drug Delivery Revenue by Application (2015-2020) (US$ Million)

Table 34. Global Ocular Drug Delivery Revenue Market Share Forecast by Application (2021-2026)

Table 35. United States Ocular Drug Delivery Sales (K Doses) of Key Companies (2015-2020)

Table 36. United States Ocular Drug Delivery Sales Share by Company (2015-2020)

Table 37. United States Ocular Drug Delivery Revenue (US$ Million) by Company (2015-2020)

Table 38. United States Ocular Drug Delivery Sales (K Doses) by Type (2015-2020)

Table 39. United States Ocular Drug Delivery Sales Share by Type (2015-2020)

Table 40. United States Ocular Drug Delivery Revenue (US$ Million) Market Share by Type (2015-2020)

Table 41. United States Ocular Drug Delivery Price (K Doses) by Type (2015-2020)

Table 42. United States Ocular Drug Delivery Sales (K Doses) by Type (2021-2026)

Table 43. United States Ocular Drug Delivery Sales Share by Type (2021-2026)

Table 44. United States Ocular Drug Delivery Revenue (US$ Million) Market Share by Type (2021-2026)

Table 45. United States Ocular Drug Delivery Revenue Share by Type (2021-2026)

Table 46. United States Ocular Drug Delivery Price (K Doses) by Type (2021-2026)

Table 47. United States Ocular Drug Delivery Sales (K Doses) by Application (2015-2020)

Table 48. United States Ocular Drug Delivery Sales Share by Application (2015-2020)

Table 49. United States Ocular Drug Delivery Revenue (US$ Million) Market Share by Application (2015-2020)

Table 50. United States Ocular Drug Delivery Sales (K Doses) by Application (2021-2026)

Table 51. United States Ocular Drug Delivery Sales Share by Application (2021-2026)

Table 52. United States Ocular Drug Delivery Revenue (US$ Million) Market Share by Application (2021-2026)

Table 53. United States Ocular Drug Delivery Revenue Share by Application (2021-2026)

Table 54. North America Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)

Table 55. North America Ocular Drug Delivery Sales Market Share by Country (2015-2020)

Table 56. North America Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)

Table 57. North America Ocular Drug Delivery Revenue Market Share by Country (2015-2020)

Table 58. Europe Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)

Table 59. Europe Ocular Drug Delivery Sales Market Share by Country (2015-2020)

Table 60. Europe Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)

Table 61. Europe Ocular Drug Delivery Revenue Market Share by Country (2015-2020)

Table 62. Asia Pacific Ocular Drug Delivery Sales by Region (2015-2020) (K Doses)

Table 63. Asia Pacific Ocular Drug Delivery Sales Market Share by Region (2015-2020)

Table 64. Asia Pacific Ocular Drug Delivery Revenue by Region (2015-2020) (US$ Million)

Table 65. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region (2015-2020)

Table 66. Latin America Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)

Table 67. Latin America Ocular Drug Delivery Sales Market Share by Country (2015-2020)

Table 68. Latin Americaa Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)

Table 69. Latin America Ocular Drug Delivery Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Ocular Drug Delivery Sales by Country (2015-2020) (K Doses)

Table 71. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country (2015-2020)

Table 72. Middle East and Africa Ocular Drug Delivery Revenue by Country (2015-2020) (US$ Million)

Table 73. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country (2015-2020)

Table 74. OCULAR THERAPEUTIX, INC Corporation Information

Table 75. OCULAR THERAPEUTIX, INC Description and Business Overview

Table 76. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 77. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product

Table 78. OCULAR THERAPEUTIX, INC Recent Development

Table 79. Alimera Sciences Corporation Information

Table 80. Alimera Sciences Description and Business Overview

Table 81. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 82. Alimera Sciences Product

Table 83. Alimera Sciences Recent Development

Table 84. Allergan, Plc Corporation Information

Table 85. Allergan, Plc Description and Business Overview

Table 86. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 87. Allergan, Plc Product

Table 88. Allergan, Plc Recent Development

Table 89. EyeGate Pharma Corporation Information

Table 90. EyeGate Pharma Description and Business Overview

Table 91. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 92. EyeGate Pharma Product

Table 93. EyeGate Pharma Recent Development

Table 94. Valeant Pharmaceuticals International, Inc Corporation Information

Table 95. Valeant Pharmaceuticals International, Inc Description and Business Overview

Table 96. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 97. Valeant Pharmaceuticals International, Inc Product

Table 98. Valeant Pharmaceuticals International, Inc Recent Development

Table 99. Envisia Therapeutics Corporation Information

Table 100. Envisia Therapeutics Description and Business Overview

Table 101. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 102. Envisia Therapeutics Product

Table 103. Envisia Therapeutics Recent Development

Table 104. Clearside Biomedical Corporation Information

Table 105. Clearside Biomedical Description and Business Overview

Table 106. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 107. Clearside Biomedical Product

Table 108. Clearside Biomedical Recent Development

Table 109. Graybug Vision Inc Corporation Information

Table 110. Graybug Vision Inc Description and Business Overview

Table 111. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 112. Graybug Vision Inc Product

Table 113. Graybug Vision Inc Recent Development

Table 114. Taiwan Liposome Company Corporation Information

Table 115. Taiwan Liposome Company Description and Business Overview

Table 116. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 117. Taiwan Liposome Company Product

Table 118. Taiwan Liposome Company Recent Development

Table 119. Santen Pharmaceutical Corporation Information

Table 120. Santen Pharmaceutical Description and Business Overview

Table 121. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)

Table 122. Santen Pharmaceutical Product

Table 123. Santen Pharmaceutical Recent Development

Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 125. Key Challenges

Table 126. Market Risks

Table 127. Main Points Interviewed from Key Ocular Drug Delivery Players

Table 128. Ocular Drug Delivery Customers List

Table 129. Ocular Drug Delivery Distributors List

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Ocular Drug Delivery Product Picture

Figure 2. Global Ocular Drug Delivery Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Ocular Drug Delivery Sales Market Share by Application in 2020 & 2026

Figure 6. Hospitals

Figure 7. Ambulatory Surgical Centers

Figure 8. Ophthalmic Clinics

Figure 9. Homecare Settings

Figure 10. Ocular Drug Delivery Report Years Considered

Figure 11. Global Ocular Drug Delivery Market Size 2015-2026 (US$ Million)

Figure 12. Global Ocular Drug Delivery Sales 2015-2026 (K Doses)

Figure 13. Global Ocular Drug Delivery Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Ocular Drug Delivery Sales Market Share by Region (2015-2020)

Figure 15. Global Ocular Drug Delivery Sales Market Share by Region in 2019

Figure 16. Global Ocular Drug Delivery Revenue Market Share by Region (2015-2020)

Figure 17. Global Ocular Drug Delivery Revenue Market Share by Region in 2019

Figure 18. Global Ocular Drug Delivery Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Ocular Drug Delivery Revenue in 2019

Figure 20. Ocular Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Ocular Drug Delivery Sales Market Share by Type (2015-2020)

Figure 22. Global Ocular Drug Delivery Sales Market Share by Type in 2019

Figure 23. Global Ocular Drug Delivery Revenue Market Share by Type (2015-2020)

Figure 24. Global Ocular Drug Delivery Revenue Market Share by Type in 2019

Figure 25. Global Ocular Drug Delivery Market Share by Price Range (2015-2020)

Figure 26. Global Ocular Drug Delivery Sales Market Share by Application (2015-2020)

Figure 27. Global Ocular Drug Delivery Sales Market Share by Application in 2019

Figure 28. Global Ocular Drug Delivery Revenue Market Share by Application (2015-2020)

Figure 29. Global Ocular Drug Delivery Revenue Market Share by Application in 2019

Figure 30. United States Ocular Drug Delivery Sales Growth Rate 2015-2026 (K Doses)

Figure 31. United States Ocular Drug Delivery Revenue Growth Rate 2015-2026 (US$ Million)

Figure 32. United States Ocular Drug Delivery Market Share in Global Market 2015-2026

Figure 33. United States 5 and 10 Largest Ocular Drug Delivery Players Market Share by Revenue in Ocular Drug Delivery in 2019

Figure 34. United States Ocular Drug Delivery Revenue Share by Type (2015-2020)

Figure 35. United States Ocular Drug Delivery Revenue Growth Rate by Type in 2015 & 2019

Figure 36. United States Ocular Drug Delivery Revenue Share by Application (2015-2020)

Figure 37. United States Ocular Drug Delivery Revenue Growth Rate by Application in 2015 & 2019

Figure 38. North America Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)

Figure 39. North America Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)

Figure 40. North America Ocular Drug Delivery Sales Market Share by Country in 2019

Figure 41. North America Ocular Drug Delivery Revenue Market Share by Country in 2019

Figure 42. U.S. Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 43. U.S. Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. Canada Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 45. Canada Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Europe Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)

Figure 47. Europe Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)

Figure 48. Europe Ocular Drug Delivery Sales Market Share by Country in 2019

Figure 49. Europe Ocular Drug Delivery Revenue Market Share by Country in 2019

Figure 50. Germany Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 51. Germany Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. France Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 53. France Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. U.K. Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 55. U.K. Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Italy Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 57. Italy Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Russia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 59. Russia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Asia Pacific Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)

Figure 61. Asia Pacific Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)

Figure 62. Asia Pacific Ocular Drug Delivery Sales Market Share by Region in 2019

Figure 63. Asia Pacific Ocular Drug Delivery Revenue Market Share by Region in 2019

Figure 64. China Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 65. China Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Japan Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 67. Japan Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. South Korea Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 69. South Korea Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. India Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 71. India Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Australia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 73. Australia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Taiwan Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 75. Taiwan Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Indonesia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 77. Indonesia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Thailand Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 79. Thailand Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Malaysia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 81. Malaysia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Philippines Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 83. Philippines Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Vietnam Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 85. Vietnam Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Latin America Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)

Figure 87. Latin America Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)

Figure 88. Latin America Ocular Drug Delivery Sales Market Share by Country in 2019

Figure 89. Latin America Ocular Drug Delivery Revenue Market Share by Country in 2019

Figure 90. Mexico Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 91. Mexico Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Brazil Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 93. Brazil Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Argentina Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 95. Argentina Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Middle East and Africa Ocular Drug Delivery Sales Growth Rate 2015-2020 (K Doses)

Figure 97. Middle East and Africa Ocular Drug Delivery Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Ocular Drug Delivery Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Ocular Drug Delivery Revenue Market Share by Country in 2019

Figure 100. Turkey Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 101. Turkey Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 103. Saudi Arabia Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Ocular Drug Delivery Sales Growth Rate (2015-2020) (K Doses)

Figure 105. U.A.E Ocular Drug Delivery Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Porter's Five Forces Analysis

Figure 107. Ocular Drug Delivery Value Chain

Figure 108. Channels of Distribution

Figure 109. Distributors Profiles

Figure 110. Bottom-up and Top-down Approaches for This Report

Figure 111. Data Triangulation

Figure 112. Key Executives Interviewed

OCULAR THERAPEUTIX, INC

Alimera Sciences

Allergan, Plc

EyeGate Pharma

Valeant Pharmaceuticals International, Inc

Envisia Therapeutics

Clearside Biomedical

Graybug Vision Inc

Taiwan Liposome Company

Santen Pharmaceutical

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3003

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase